▲ +147.14% Upside Potential
This price target is based on 8 analysts offering 12 month price targets for Autolus Therapeutics in the last 3 months. The average price target is $18.86, with a high forecast of $38.00 and a low forecast of $9.00. The average price target represents a 147.14% upside from the last price of $7.63.
The current consensus among 8 contributing investment analysts is to buy stock in Autolus Therapeutics. This Buy consensus rating has held steady for over two years.